Inactive Instrument
Lipidor AB Share Price Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 31/12/2017 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/12/2009 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 30/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 31/12/2016 |
| Chairman | 46 | 31/12/2019 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 31/05/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -50.34% | -59.44% | - | - | 92.63K | ||
| +4.46% | +4.92% | +82.07% | +134.31% | 1,141B | ||
| +0.85% | +4.81% | +53.77% | +58.51% | 659B | ||
| +2.72% | +6.92% | +28.99% | +77.15% | 470B | ||
| +0.59% | +1.99% | +40.82% | +45.30% | 366B | ||
| -0.13% | +2.63% | +24.07% | +41.11% | 302B | ||
| -0.94% | +2.10% | -0.18% | +11.99% | 254B | ||
| +4.02% | +6.29% | +49.67% | +68.96% | 239B | ||
| +0.03% | +0.67% | -13.12% | -52.39% | 207B | ||
| +2.90% | +8.63% | +25.11% | +94.52% | 183B | ||
| Average | -4.22% | +4.10% | +32.36% | +53.27% | 424.55B | |
| Weighted average by Cap. | +0.41% | +4.31% | +46.75% | +74.09% |
Employees
4
Sector
Pharmaceuticals
















